Filtered By:
Specialty: Cardiology
Infectious Disease: Coronavirus
Vaccination: Vaccines

This page shows you your search results in order of date.

Order by Relevance | Date

Total 4 results found since Jan 2013.

A case report overlapped vaccine and COVID-19 in disseminated atherosclerosis
Clin Exp Vaccine Res. 2023 Apr;12(2):172-175. doi: 10.7774/cevr.2023.12.2.172. Epub 2023 Apr 30.ABSTRACTCoronavirus disease 2019 (COVID-19) has become a part of our lives now and we have no more effective way of coping than a vaccine. COVID-19 is a disease that causes severe thrombosis outside the respiratory tract. Vaccines also protect us in this respect, but in some rare cases, thrombosis has been found to develop after vaccination (much less frequently than COVID-19). What was interesting in our case was that it showed how a disaster could happen under three factors that predispose to thrombosis. A 65-year-old female p...
Source: Atherosclerosis - May 22, 2023 Category: Cardiology Authors: Vecihe Bayrak Source Type: research

Clinical Characteristics of Patients with Acute Ischemic Stroke Previously Vaccinated Against COVID-19
CONCLUSIONS: There are no significant differences in clinical characteristics of stroke in vaccinated compared to unvaccinated patients. We did not find a connection between vaccination and stroke.PMID:35447380 | PMC:PMC8977441 | DOI:10.1016/j.jstrokecerebrovasdis.2022.106483
Source: Atherosclerosis - April 21, 2022 Category: Cardiology Authors: Marija Stamenkovi ć Ljiljana Radmilo Mirjana Jovi ćević Tamara Rabi- Žikić Marija Žarkov Svetlana Ru žička-Kaloci Svetlana Simi ć Aleksandar Stamenkovi ć Jelena Dangi ć Goran Knezovi ć Željko Živanović Source Type: research

Unexplained arterial thrombosis: approach to diagnosis and treatment
We present a structured approach to diagnosis with consideration of common causes, including atherosclerosis and embolism, as well as uncommon causes, including medications and substances, vascular and anatomic abnormalities, systemic disorders, and thrombophilias. We highlight areas of management that have evolved within the past 5 years, including the use of dual-pathway inhibition in atherosclerotic disease, antithrombotic therapy selection in embolic stroke of undetermined source and left ventricular thrombus, the role of closure of patent foramen ovale for secondary stroke prevention, and the thrombotic potential of c...
Source: Atherosclerosis - December 10, 2021 Category: Cardiology Authors: Jori E May Stephan Moll Source Type: research